We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > opioid withdrawal

News List

FDA approves first non-opioid treatment for opioid withdrawal biospectrumasia
May 18, 2018
Lucemyra is not a treatment for opioid use disorder (OUD), but can be used as part of a broader, long-term treatment plan for managing OUD.
FDA committee votes to approve lofexidine for opioid withdrawal pharmaceutical-technology
April 03, 2018
The US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee has voted to approve lofexidine hydrochloride to treat symptoms of opioid withdrawal.
FDA OKs behind-the-ear device for opioid withdrawal fiercebiotechFDA OKs behind-the-ear device for opi
November 20, 2017
Innovative Health Solutions has bagged an FDA clearance for its nerve field stimulator that treats the symptoms of opioid withdrawal.